Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 280

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 280
---
 powers, preferences and the relative, participating, optional or other special rights and
any qualifications, limitations and restrictions of the shares of each series of Preferred Stock. The authorized shares of the Preferred
Stock are available for issuance without further action by our stockholders, unless such action is required by applicable law or the
rules of any stock exchange on which the securities may be listed. If the approval of our stockholders is not required for the issuance
of shares of the Preferred Stock, the Board may determine not to seek stockholder approval.

The Board will be able to,
without stockholder approval, issue Preferred Stock with voting and other rights that could adversely affect the voting power and other
rights of the holders of the Common Stock and could have anti-takeover effects. The ability of the Board to issue Preferred Stock without
stockholder approval could have the effect of delaying, deferring or preventing a change of control of us or the removal of existing
management.

Series A Convertible Preferred Stock

We designated 12,580 shares
of our authorized and unissued Preferred Stock as Series A Preferred Stock and established the rights, preferences and privileges of
the Series A Preferred Stock pursuant to the Series A Certificate of Designations filed with the Secretary of State of the State of Delaware,
as summarized below.

General. Each share
of Series A Preferred Stock has a stated value of $1,000 per share and, when issued, the Series A Preferred Stock was fully paid and
non-assessable.

Ranking. The Series
A Preferred Stock, with respect to the payment of dividends, distributions and payments upon the liquidation, dissolution and winding
up of us, ranks senior to all capital stock of us unless the Required Holders (as defined in the Series A Certificate of Designations)
consent to the creation of other capital stock of us that is senior or equal in rank to the Series A Preferred Stock.

Dividends. The holders
of Series A Preferred Stock will be entitled to dividends, on an as-if converted basis, equal to and in the same form as dividends actually
paid on shares of Common Stock, when and if actually paid.

Purchase Rights.
If at any time we grant, issue or sell any options, convertible securities, or rights to purchase stock, warrants, securities or other
property pro rata to all or substantially all of the record holders of any class of Common Stock (the “Purchase Rights”),
then each holder of Series A Preferred Stock will be entitled to acquire, upon the terms applicable to